Integrated BioTherapeutics, Inc.
Edit

Integrated BioTherapeutics, Inc.

http://www.integratedbiotherapeutics.com/
Last activity: 24.03.2022
Active
Categories: DefenseDevelopmentFinTechGovTechHealthTechMedTechNewsResearchScienceService
Integrated BioTherapeutics Inc (IBT) is the 2009 Emerging Company of the Year in Maryland. IBT is a research-based company dedicated to development of vaccines and biotherapeutic molecules targeting emerging infectious agents. We are located in Gaithersburg, Maryland.

Our primary areas of focus is on Ebola and Marburg viral hemorrhagic fevers and staph aureus. IBT is developing a panfilovirus vaccine under a contract with NIAID. In addition IBT is also testing an SEB vaccine in phase I trials sponsored by NIH. IBT has a close working arrangement with many of the United States government agencies including the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), National Cancer Institute (NCI), National Institute of Health (NIH), and the Department of Defense (DOD).

IBT Bioservices is our contract R&D services business. IBT Bioservices is developing screening assays and disease models to identify antiviral and antibacterial compounds and therapeutics for client companies. In addition, we offer contract testing using the Mesoscale Discovery platform by MSD. You can learn more about IBT Bioservices at www.ibtbioservices.com.
Mentions
4
Location: United States, Maryland, Rockville
Employees: 11-50
Total raised: $6.6M
Founded date: 2005

Investors 1

DateNameWebsite
-CARB-Xcarb-x.org

Funding Rounds 1

DateSeriesAmountInvestors
02.08.2017Grant$6.6M-

Mentions in press and media 4

DateTitleDescription
24.03.2022Integrated Biotherapeutics Awarded $3.55M Grant to Study Immune Correlates of Protection Against Recurrent Staphylococcal InfectionThis is a crucial step toward understanding the mechanisms of protection that can guide us toward successful development of an effective MRSA vaccine. ROCKVILLE, Md. (PRWEB) March 24, 2022 Integrated BioTherapeutics Inc. (IBT), a Maryland b...
19.05.2021Integrated BioTherapeutics Inc. Awarded $16.3M Contract from the National Institute of Allergy and Infectious Diseases to Develop a Treatment for Marburg Virus DiseaseROCKVILLE, Md. (PRWEB) May 19, 2021 Integrated BioTherapeutics Inc. (IBT), a Maryland biotechnology company specializing in emerging infectious diseases, announced today the receipt of a contract valued at up to $16.3 million from the Natio...
02.08.2017Integrated BioTherapeutics Receives $6.6M Grant from NIAIDIntegrated BioTherapeutics Inc., a Rockville, Md.-based a biotechnology company focused on the discovery of novel vaccines and therapies for emerging infectious diseases, has been awarded a $6.6m grant from the National Institute of Allergy...
-Integrated BioTherapeutics“Home - Integrated biotherapeutics”

Reviews 0

Sign up to leave a review

Sign up Log In